Lactobacillus reuteri strain produced using Pylopass technology
DESCRIPTION :
Lactobacillus reuteri strain was isolated from tens of thousands of other bacterial strains. In this painstaking process, a unique species of bacteria was isolated that has the greatest activity against the H. pylori strain. Pylopass® resists the low pH in the stomach by a suitable survival mechanism that is not affected by hydrochloric acid. It does not require temperature-controlled transport and storage.
Pylopass® manufacturing process:
Microbial fermentation is one of the specialties of Novozymes (Pylopass® manufacturer). Pylopass® is made by fermenting the patented L. reuteri under controlled conditions to achieve maximum aggregation capacity. After fermentation, the cells are harvested, embedded in a matrix and spray dried at low temperature.
Pylopass® is a registered trademark of Novozymes Berlin GmbH
APPLICATION : p>
1 capsule daily after breakfast
CONTRAINDICATIONS:
Do not exceed the recommended daily dose. Dietary supplements cannot be used as a substitute (substitute) for a varied diet. The preparation should not be used by pregnant women, breastfeeding women and children under 3 years old.
STORAGE:
Store in a closed container at room temperature, out of the reach of small children. p>
Thanks for subscribing!
This email has been registered!